Related Experiment Videos
Visual evoked potentials in diabetic children and adolescents
Diabetes Care
|May 1, 1984
Summary
Visual evoked potentials revealed abnormalities in 30% of diabetic children and adolescents. No link was found between these visual pathway changes and diabetes duration, control, or retinopathy.
Area of Science:
- Ophthalmology
- Pediatrics
- Endocrinology
Background:
- Diabetes mellitus, particularly insulin-dependent (Type 1), can affect various organ systems.
- The visual system is susceptible to microvascular complications in diabetes.
- Visual evoked potentials (VEPs) offer a non-invasive method to assess the integrity of the visual pathway.
Purpose of the Study:
- To investigate the presence and extent of visual pathway dysfunction in children and adolescents with insulin-dependent diabetes.
- To explore potential correlations between VEP abnormalities and clinical parameters of diabetes.
Main Methods:
- Visual evoked potentials (VEPs) were recorded in 30 children and adolescents diagnosed with insulin-dependent diabetes.
- Clinical data including age, duration of diabetes, metabolic control (e.g., HbA1c), and presence of retinopathy were collected.
- Statistical analyses were performed to identify correlations between VEP findings and clinical parameters.
Main Results:
- Thirty percent (30%) of the study participants exhibited significant abnormalities in their visual evoked potentials.
- No statistically significant correlation was identified between VEP abnormalities and the age of the subjects.
- No correlation was found between VEP abnormalities and the duration of diabetes, indicators of metabolic control, or the presence of retinopathy.
Conclusions:
- A notable proportion of children and adolescents with insulin-dependent diabetes show subclinical visual pathway dysfunction, as indicated by VEP abnormalities.
- Current clinical parameters like diabetes duration, metabolic control, and retinopathy status do not appear to predict these VEP changes in this pediatric cohort.
- Further research may be warranted to identify early biomarkers or specific pathogenic mechanisms underlying visual pathway involvement in pediatric diabetes.